A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.
about
Sphingosylphosphorylcholine in cancer progressThe role of epidermal sphingolipids in dermatologic diseasesPotential Applications of Phyto-Derived Ceramides in Improving Epidermal Barrier Function.Skin barrier defects in atopic dermatitisEczema and ceramides: an update.Canine epidermal lipid sampling by skin scrub revealed variations between different body sites and normal and atopic dogsSphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.Transcription factor Ctip2 controls epidermal lipid metabolism and regulates expression of genes involved in sphingolipid biosynthesis during skin development.Filaggrin inhibits generation of CD1a neolipid antigens by house dust mite-derived phospholipase.Current evidence of skin barrier dysfunction in human and canine atopic dermatitis.The stratum corneum: the rampart of the mammalian body.Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.Lipid-specific T cells and the skin.Dry skin in the winter is related to the ceramide profile in the stratum corneum and can be improved by treatment with a Eucalyptus extract.Sphingosylphosphorylcholine attenuated β-amyloid production by reducing BACE1 expression and catalysis in PC12 cells.The roughness of lip skin is related to the ceramide profile in the stratum corneum.Synthesis and degradation of long-chain base phosphates affect fumonisin B1-induced cell death in Arabidopsis thaliana.Effect of glycation focusing on the process of epidermal lipid synthesis in a reconstructed skin model and membrane fluidity of stratum corneum lipids.
P2860
Q26778510-E9B7025D-E3AA-48F2-BB32-985DCF7D6CB3Q28075846-F052A383-26F7-415B-9543-74D2DF1CDD71Q30313257-C132E7E0-16FC-4A65-A508-83FEABDD50A0Q30405464-183B1E0C-DFF2-4AFF-897C-53E207E71C39Q34358580-BA75C23D-7238-41CD-B1C9-E78E28A244ECQ35205061-4442F362-96CD-44AF-919F-13E4A885F984Q35324757-E03EA0B2-F1FD-482A-8212-29DFF30F198BQ36565839-DC37870A-6C13-4A5A-B86F-717591DD5B3FQ36916564-7003AE7F-35DE-4173-A24A-1962EB99B7DFQ37854092-CF2CE69E-8306-4269-92C1-4AF59CE2CC16Q38075148-187363AC-36C1-4341-B533-6A52569FAC1FQ38152889-54B597FF-91DF-4EAB-BF5E-500B7D41CCB4Q38964257-990F91D4-7BFB-4A62-B21E-4695E9563044Q39231669-D4491F85-42FF-43AE-9EBF-15DCFED229D9Q45933075-CD09E4E4-5252-433A-ACDC-D31A7869B8E3Q46561963-583E0B1B-8408-432E-85F0-620ABB5646EBQ50183050-3A7341C4-4E74-4B3D-B8BB-1BB7942E53A8Q50300065-554D18A1-F794-4161-BF20-BAB793ABB158
P2860
A possible mechanism underlying the ceramide deficiency in atopic dermatitis: expression of a deacylase enzyme that cleaves the N-acyl linkage of sphingomyelin and glucosylceramide.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@en
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@nl
type
label
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@en
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@nl
prefLabel
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@en
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@nl
P921
P1476
A possible mechanism underlyin ...... gomyelin and glucosylceramide.
@en
P2093
Genji Imokawa
P356
10.1016/J.JDERMSCI.2009.04.006
P577
2009-05-13T00:00:00Z